IDEAYA Biosciences, Inc. Other Non-Current Assets
IDEAYA Biosciences, Inc. (IDYA) had Other Non-Current Assets of $75.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2025-02-18
- 2024-06-30: Other Assets, Noncurrent $75.00K.
- 2024-03-31: Other Assets, Noncurrent $92.00K.
- 2023-12-31: Other Assets, Noncurrent $25.00K.
- 2023-09-30: Other Assets, Noncurrent $105.00K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2024-06-30 | $75.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $92.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $25.00K 10-K · filed 2025-02-18 |
| 2023-09-30 | $105.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $108.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $114.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $99.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $146.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $174.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $256.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $291.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $217.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $791.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $111.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $82.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $173.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $26.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $16.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $16.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $18.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $25.00K 10-Q · filed 2019-08-12 |
| 2018-12-31 | $46.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |